$60.78
-1.62-2.6%
Last update: Nov 10, 4:00 PM
Ingevity Corp
NGVTNYSE
Ingevity rose 21.9% from $49.86 to $60.78, ahead of the S&P 500's +10.0%. Its worst day was Nov 5 (−13.6%), and its low came Nov 17 at $47.12.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Ingevity closed at its lowest level of the year, 5.5% below where the year started.
−4.6% · S&P 500 −0.9%
EPS of $0.64 missed the $0.69 estimate on $255.1M revenue (est. $257.3M); FY revenue guidance of $1.1B–$1.2B against the $1.2B consensus.
+1.3% · S&P 500 −0.6%
EPS of $1.15 beat the $0.83 estimate on $258.0M revenue (est. $253.6M); FY revenue guidance of $1.1B–$1.1B against the $1.2B consensus.
−4.9% · S&P 500 −0.3%
EPS of $1.74 beat the $1.34 estimate on $314.1M revenue (est. $303.7M); FY revenue guidance of $1.1B–$1.1B against the $1.1B consensus.
−0.6% · S&P 500 +1.7%
EPS of $1.63 beat the $1.58 estimate on $305.1M revenue (est. $304.4M); FY revenue guidance of $1.1B against the $1.1B consensus.
−13.6%, the year's worst day · S&P 500 −4.4%
Where it ended: a close of $60.78 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.89, revenue est. $235.5M).
Nothing in the past 12 months.
All NGVT dividend history
